Line 56: | Line 56: | ||
<div class="main_content"> | <div class="main_content"> | ||
− | <div class="title"> | + | <div class="title">Measurement</div> |
<h2>Original Part: BBa_K1189019</h2> | <h2>Original Part: BBa_K1189019</h2> | ||
<article> | <article> | ||
− | + | ||
</article> | </article> | ||
Line 72: | Line 72: | ||
<article> | <article> | ||
− | + | ||
</article> | </article> | ||
Line 78: | Line 78: | ||
<article> | <article> | ||
− | + | ||
</article> | </article> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure hundred" src=" | + | <img class="figure hundred" src=""> |
<figcaption> | <figcaption> | ||
<b>Figure 2:</b> Alignment of the protein sequences of the wild-type and the mutated human ferritin heavy chain. The Alignment was produced with Clustal Omega (Goujon et al., 2010, Sievers et al., 2011). | <b>Figure 2:</b> Alignment of the protein sequences of the wild-type and the mutated human ferritin heavy chain. The Alignment was produced with Clustal Omega (Goujon et al., 2010, Sievers et al., 2011). | ||
Line 89: | Line 89: | ||
<article> | <article> | ||
− | + | ||
</article> | </article> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure hundred" src=" | + | <img class="figure hundred" src=""> |
<figcaption> | <figcaption> | ||
<b>Figure 3:</b> Protein structures of the wild-type human ferritin (<b>A</b>, RCSB ID 4oYN) and the mutated human ferritin (<b>B</b>, RCSB ID 3ES3). Despite the mutations of ten amino acids the ferritin retains its shape. The protein structeres were generated with Chimera (Pettersen et al., 2004). | <b>Figure 3:</b> Protein structures of the wild-type human ferritin (<b>A</b>, RCSB ID 4oYN) and the mutated human ferritin (<b>B</b>, RCSB ID 3ES3). Despite the mutations of ten amino acids the ferritin retains its shape. The protein structeres were generated with Chimera (Pettersen et al., 2004). | ||
Line 103: | Line 103: | ||
<!-- | <!-- | ||
<article> | <article> | ||
− | + | ||
</article> --> | </article> --> | ||
<figure role="group"> | <figure role="group"> | ||
− | <img class="figure hundred" src=" | + | <img class="figure hundred" src=""> |
<figcaption> | <figcaption> | ||
<b>Figure 4:</b> Possible applications of nanoparticles produced with ferritin. | <b>Figure 4:</b> Possible applications of nanoparticles produced with ferritin. | ||
Line 122: | Line 122: | ||
<b>Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.</b> </br> | <b>Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.</b> </br> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</div> | </div> |
Revision as of 18:05, 16 October 2018
Measurement
Original Part: BBa_K1189019
Improved Human Ferritin: BBa_K2638999
Outlook
Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.
Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.